Cornerstone Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15
Closed -$138 78
2023
Q1
$138 Hold
15
﹤0.01% 243
2022
Q4
$172 Hold
15
﹤0.01% 236
2022
Q3
$256 Hold
15
﹤0.01% 240
2022
Q2
$323 Hold
15
﹤0.01% 244
2022
Q1
$555 Hold
15
﹤0.01% 244
2021
Q4
$683 Buy
+15
New +$783 ﹤0.01% 221

Other funds holding CDNA

Cornerstone Management's CDNA Position: Q2 2023 in Review

Cornerstone Management sold out of CareDx (CDNA) in Q2 2023, closing a stake of 15 shares — an estimated $138 sold.

Cornerstone Management first reported a position in CDNA in Q4 2021 and held it in 6 quarters. The position peaked at $683 in Q4 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2023.

  • Cornerstone Management reported no remaining CareDx position as of Q2 2023 after selling out during the quarter.
  • Cornerstone Management sold 15 CareDx shares in Q2 2023, an estimated $138.
  • Cornerstone Management first reported a position in CareDx in Q4 2021 and held it in 6 quarters.
  • Cornerstone Management's CareDx position peaked at $683 in Q4 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2023.

Based on Cornerstone Management's 13F filing for Q2 2023, filed 10 Aug 2023.